These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1717772)

  • 1. New approaches to the prevention of thrombotic restenosis after angioplasty or thrombolysis.
    Golino P; Chiariello M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S41-7. PubMed ID: 1717772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
    Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Nomoto K; Atsuchi Y; Tahara M; Tanaka H
    J Cardiol; 1990; 20(4):849-59. PubMed ID: 2151948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic therapy: enhancement by platelet and platelet-derived mediator antagonists.
    Willerson JT; Golino P; McNatt J; Eidt J; Yao SK; Buja LM
    Mol Biol Med; 1991 Apr; 8(2):235-43. PubMed ID: 1806765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of direct coronary angioplasty in the course of acute myocardial infarction].
    Sheiban I; Tonni S; Trevi G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):129-42. PubMed ID: 8020010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reocclusion/restenosis after coronary artery bypass surgery, percutaneous transluminal coronary angioplasty and thrombolysis.
    Simoons ML
    Z Kardiol; 1989; 78 Suppl 3():35-41. PubMed ID: 2530711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.
    Roux SP; Tschopp TB; Kuhn H; Steiner B; Hadváry P
    J Pharmacol Exp Ther; 1993 Jan; 264(1):501-8. PubMed ID: 8423548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coronary angioplasty in acute coronary syndrome].
    Martínez Elbal L; Gómez Recio M
    Rev Port Cardiol; 1990 May; 9(5):463-70. PubMed ID: 2206592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of heparin-coated stent in early setting of acute myocardial infarction.
    Shin EK; Son JW; Sohn MS; Jin DK; Park GS; Koh KK; Ahn TH; Choi IS
    Catheter Cardiovasc Interv; 2001 Mar; 52(3):306-12. PubMed ID: 11246241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New aspects of blood coagulation inhibitory therapy within the scope of percutaneous transluminal coronary angioplasty (PTCA)].
    Schächinger V; Zeiher AM
    Z Kardiol; 1995 Sep; 84(9):651-67. PubMed ID: 8525667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment.
    Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):194-202. PubMed ID: 7511747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction and prevention of reocclusion after coronary thrombolysis for acute myocardial infarction based on analysis of the coronary morphology with angiography].
    Ishihara M; Sato H; Tateishi H; Uchida T; Dote K
    J Cardiol; 1991; 21(3):625-30. PubMed ID: 1843513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IIb/IIIa inhibitors in acute myocardial infarction.
    Montalescot G
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S71-5. PubMed ID: 10070824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Revascularization measures after acute myocardial infarct].
    Erbel R; Spiecker M; Rupprecht HJ; Darius H; Görge G; Haude M; Dietz U; Meyer J
    Z Kardiol; 1993; 82 Suppl 2():157-69. PubMed ID: 8328196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The possible limits of thrombolysis: reocclusion and reperfusion damage].
    Ambrosio G; Golino P; Chiariello M
    Cardiologia; 1991 Dec; 36(12 Suppl 1):421-33. PubMed ID: 1841798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in intracoronary thrombolysis treatment].
    Kawai C
    J Cardiol; 1988 Dec; 18(4):1149-53. PubMed ID: 3267723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does platelet glycoprotein IIb/IIIa receptor antibody improve in-hospital outcome of coronary stenting in high-risk thrombus containing lesions?
    Piamsomboon C; Wong PM; Mathur A; Singh D; Liu MW; Baxley WA; Iyer SS; Dean LS; Roubin GS
    Catheter Cardiovasc Interv; 1999 Apr; 46(4):415-20. PubMed ID: 10216005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of left ventricular aneurysm formation and left ventricular remodeling caused by percutaneous transluminal coronary angioplasty performed 24-48 hours after onset of acute myocardial infarction].
    Kanamasa K; Ogawa I; Koka H; Ishida N; Sasaki T; Nakabayashi T; Nakagawa K; Takada K; Kato H; Otani N; Ishikawa K; Katori R
    J Cardiol; 1996 Oct; 28(4):199-205. PubMed ID: 8934335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.